miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinaseFrancesca Maria Orlandella, Giuliana Salvatore|British Journal of Cancer|2020Cited by 37
<i>TWIST1</i>/miR-584/<i>TUSC2</i> pathway induces resistance to apoptosis in thyroid cancer cellsFrancesca Maria Orlandella, Giuliana Salvatore|Oncotarget|2016Cited by 30
Preclinical Imaging Evaluation of miRNAs’ Delivery and Effects in Breast Cancer Mouse Models: A Systematic ReviewFrancesca Maria Orlandella, Giuliana Salvatore|Cancers|2021Cited by 5
Preclinical Imaging Evaluation of MiRNAs Delivery and Effects in Breast Cancer Mouse Models: A Systematic ReviewFrancesca Maria Orlandella, Giuliana Salvatore|Research Square|2021Cited by 3